Psoriasis - Medical / Health Care

SFA Therapeutics will begin a Phase 1b trial of patients suffering from Mild to moderate Psoriasis 3Q2020. The study will be conducted in conjunction with Temple University in Philadelphia, PA. Estimated start date is 1 October, 2020.